Jun 11, 2019 / 03:00PM GMT
Patrick B. Donnelly - Goldman Sachs Group Inc., Research Division - Equity Analyst
All right. We can look to get started here. Thanks for being here. I'm Patrick Donnelly, the tools and diagnostics analyst here at Goldman. Excited to have Agilent with us to start the conference. I just have read a disclaimer really quick. We have to read it at the start of each day.
We're required to make certain disclosures in public appearances about Goldman Sachs' relationships with companies that we discuss. The disclosures relate to investment banking relationships, compensation received or 1% or more ownership. We're prepared to read aloud disclosures for any issuer upon request. However, these disclosures are available in our most recent reports available to you as clients on our firm portals. Disclosures and updates to those disclosures are also available by ticker on the firm's public website. The views stated by non-Goldman Sachs personnel do not necessarily reflect those of Goldman Sachs.
Robert W. McMahon - Agilent Technologies, Inc. - Senior VP & CFO
Agilent Technologies Inc at Goldman Sachs Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot